PMV Pharmaceuticals, Inc. (PMVP) is looking like an interesting pick from a technical perspective, a

PMV Pharmaceuticals reports 46% ORR in Phase 2 trial for ovarian cancer drug rezatapopt. NDA submiss

Shares of Pyxis Tankers Inc (NASDAQ:PXS) rose sharply in pre-market trading after the company report

PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “C

PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “C

PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “C

PMV Pharmaceuticals (PMVP) might move higher on growing optimism about its earnings prospects, which

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.34) per share which beat the analyst conse

PRINCETON, N.J., Aug. 14, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “C

PMV Pharmaceuticals (PMVP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism a

PMV Pharmaceuticals (PMVP) is technically in oversold territory now, so the heavy selling pressure m

Oppenheimer analyst Jeff Jones maintains PMV Pharmaceuticals (NASDAQ:PMVP) with a Outperform and

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.34) per share which beat the analyst conse

PMV Pharmaceuticals, Inc. ("PMV Pharma" or the "Company"; Nasdaq: PMVP), a precision

Rich Heyman to retire from PMV Pharma Board of Directors; Laurie Stelzer, Director since 2020, appoi

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.34) per share which beat the analyst conse

PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “

PMV Pharmaceuticals, Inc. (("PMV Pharma" or the "Company", NASDAQ:PMVP), a precision

Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) and PMV Pharmaceuticals (NASDAQ: PMVP - Get

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.40) per share which met the analyst consen

Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Mole

PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “C

PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study

PMV Pharmaceuticals, Inc. PMVP on Wednesday released interim data from the Phase 2 pivotal portion o

PMV Pharma's Phase 2 trial shows 33% response in TP53 Y220C-mutated tumors, with ovarian cancer

PYNNACLE Phase 2 pivotal clinical trial interim data include confirmed responses observed in eight t

PRINCETON, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “

PMV Pharmaceuticals (PMVP) Q2 Loss Jumps

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.41) per share which missed the analyst con

PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “C

PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: P

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.34) per share which beat the analyst conse

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and m

PMV Pharmaceuticals (PMVP) witnesses a hammer chart pattern, indicating support found by the stock a

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(1.14) per share which missed the analyst con

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as m

PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a preci

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.37) per share which missed the analyst con

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and m

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.02) per share which beat the analyst conse

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and m

Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ:PMVP, ", PMV Pharma", )))) t

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the comp

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enh